1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Lung Cancer Diagnostics Market
2.2. Global Lung Cancer Diagnostics Market, By Diagnostic Test Type, 2023 (US$ Million)
2.3. Global Lung Cancer Diagnostics Market, By Cancer Type, 2023 (US$ Million)
2.4. Global Lung Cancer Diagnostics Market, By End-User, 2023 (US$ Million)
2.5. Global Lung Cancer Diagnostics Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Lung Cancer Diagnostics Market: Competitive Analysis
3.1. Market Positioning of Key Lung Cancer Diagnostics Market Vendors
3.2. Strategies Adopted by Lung Cancer Diagnostics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Lung Cancer Diagnostics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Lung Cancer Diagnostics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Imaging Tests
5.3.2. Pulmonary Function Tests
5.3.3. Lung Tissue Analysis
5.3.4. Others

6. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Non-small Cell Lung Cancer (NSCLC)
6.3.2. Small Cell Lung Cancer (SCLC)

7. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Diagnostic Centers


8. North America Lung Cancer Diagnostics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
8.3. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
8.4. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
8.5.Lung Cancer Diagnostics Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
8.5.1.1.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
8.5.1.1.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
8.5.1.2.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
8.5.1.2.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
8.5.1.3.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
8.5.1.3.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)

9. UK and European Union Lung Cancer Diagnostics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
9.3. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
9.4. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.Lung Cancer Diagnostics Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
9.5.1.1.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
9.5.1.1.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
9.5.1.2.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
9.5.1.2.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
9.5.1.3.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
9.5.1.3.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
9.5.1.4.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
9.5.1.4.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
9.5.1.5.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
9.5.1.5.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
9.5.1.6.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
9.5.1.6.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)

10. Asia Pacific Lung Cancer Diagnostics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
10.3. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
10.4. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.Lung Cancer Diagnostics Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
10.5.1.1.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
10.5.1.1.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
10.5.1.2.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
10.5.1.2.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
10.5.1.3.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
10.5.1.3.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
10.5.1.4.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
10.5.1.4.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
10.5.1.5.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
10.5.1.5.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
10.5.1.6.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
10.5.1.6.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)

11. Latin America Lung Cancer Diagnostics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
11.3. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
11.4. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
11.5.Lung Cancer Diagnostics Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
11.5.1.1.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
11.5.1.1.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
11.5.1.2.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
11.5.1.2.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
11.5.1.3.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
11.5.1.3.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)

12. Middle East and Africa Lung Cancer Diagnostics Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
12.3. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
12.4. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
12.5.Lung Cancer Diagnostics Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
12.5.1.1.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
12.5.1.1.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
12.5.1.2.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
12.5.1.2.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Lung Cancer Diagnostics Market: By Diagnostic Test Type, 2022-2032, USD (Million)
12.5.1.3.2. Lung Cancer Diagnostics Market: By Cancer Type, 2022-2032, USD (Million)
12.5.1.3.3. Lung Cancer Diagnostics Market: By End-User, 2022-2032, USD (Million)

13. Company Profile
13.1. Roche Diagnostics
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Thermo Fisher Scientific
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. bioMerieux
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Qiagen N.V.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Agilent Technologies
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. SanofiS.A.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Siemens Healthineers
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Other Notable Players
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives